Trachoma

Trachoma Alternative Indicators Study Data review

31 August–1 September 2016, World Health Organization, Geneva, Switzerland

Authors:
WHO/Department of control of neglected tropical diseases

Publication details

Editors: Dr. A. Solomon
Number of pages: v, 11 p.
Publication date: November 2017
Languages: English
WHO reference number: WHO/HTM/NTD/PCT/2017.10

Downloads


Overview

Trachoma causes blindness through repeated conjunctival infection with Chlamydia trachomatis . To eliminate trachoma as a public health problem , the World Health Organization (WHO) recommends use of the SAFE strategy (that is, surgery for advanced disease; mass drug administration of antibiotics to clear C. trachomatis infection; and facial cleanliness and environmental improvement to reduce transmission) . Current (2006) guidelines on the implementation of the A, F and E components are based on the prevalence of the sign “trachomatous inflammation—follicular”, or TF , in children aged 1–9 years.

The purpose of this meeting was to undertake an objective, open review of data generated by the study to date, consider implications for global policy and plan further work.

Related links